A new study revealed that most men and women who use marijuana in the United States do so for healthcare factors rather than recreational purposes.
According to the study published in the JAMA Open Network, 46% of common marijuana customers surveyed consume cannabis due to a healthcare situation. Meanwhile, only 22% reported they indulge in marijuana for recreational purposes.
“Adults with healthcare circumstances, specially these with respiratory circumstances, cancer, and depression, have been additional most likely to use marijuana. At present, marijuana use prevalence decreases with age, even amongst men and women with healthcare circumstances.”
“Because public perceptions of marijuana are becoming additional favorable and healthcare circumstances improve with age, older adults may possibly also come to be frequent buyers of marijuana,” the study’s authors concluded.
The investigation, which made use of information from 169,036 participants from 2016 to 2017, also showed that the major signifies of applying marijuana is smoking (77.five%, followed by consuming and vaping at 9%).
Cannabis is at present legal for healthcare purposes in 33 states in the US. But 2019 also saw additional than half of all state legislatures searching into the legalization of recreational use or possession of marijuana, illustrating a altering political landscape when it comes to the drug.
And even though the spectrum of circumstances that can be treated with healthcare marijuana varies from state to state, the circumstance in the US is a lot brighter for sufferers than across the Atlantic.
Hard fight for healthcare cannabis
In the United Kingdom, exactly where marijuana was legalized for healthcare purposes in November, sufferers in require of therapy are obtaining difficulty accessing it.
The most recent instance in the ongoing struggle to improve access to healthcare marijuana is Elaine Levy. Levy, the mother of a 25-year old lady suffering from serious epilepsy, has been forced to sell her property in order to spend for healthcare marijuana therapy.
She says that she has spent nicely more than £30,000 on medicine, which has drastically helped her daughter diagnosed with Lennox–Gastaut syndrome.
Levy has been receiving the therapy via private prescriptions rather than the National Well being Service as its stringent recommendations frequently outcome in dead-ends for healthcare marijuana sufferers.
The UK’s healthcare watchdog lately decided against recommending a cannabis-primarily based drug for treating Lennox-Gastaut syndrome and Dravet syndrome. The National Institute for Well being and Care Excellence (Good) mentioned that its selection was grounded in issues more than its price, as nicely as doubts more than the lengthy-term efficacy of the drug.